Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact

Chronic lymphocyte leukemia (CLL) is the most common leukemia in elderly individuals that is accompanied by the presence of CD5/CD19/CD20/CD23 positive, FMC7 negative and reduced levels of surface membrane Immunoglobuline (IgM & IgD), CD79b on B lymphocytes in the blood, bone marrow and lymph no...

Full description

Bibliographic Details
Main Authors: Mehrnoosh Pashaei, Mahdieh Shokrollahi, Parviz Kokhaei
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2017-02-01
Series:Basic & Clinical Cancer Research
Subjects:
Online Access:https://bccr.tums.ac.ir/index.php/bccrj/article/view/218
_version_ 1798023736716165120
author Mehrnoosh Pashaei
Mahdieh Shokrollahi
Parviz Kokhaei
author_facet Mehrnoosh Pashaei
Mahdieh Shokrollahi
Parviz Kokhaei
author_sort Mehrnoosh Pashaei
collection DOAJ
description Chronic lymphocyte leukemia (CLL) is the most common leukemia in elderly individuals that is accompanied by the presence of CD5/CD19/CD20/CD23 positive, FMC7 negative and reduced levels of surface membrane Immunoglobuline (IgM & IgD), CD79b on B lymphocytes in the blood, bone marrow and lymph nodes. Remarkably, based on the mutational IgVH status, B-CLL cases can be subdivided into two prognostic groups: the first one with presence mutation (≥ 2%) in VH gene and second one with absence mutation (≤ 2%) in VH gene that is the mutation of IgVH status, affected on progression and overall survival of CLL patients. Correspondingly, also the expression level of several markers is correlated with the mutation of IgVH status and prognosis of CLL disease. In this review we focused on relation between mutation IgVH status and CLL prognosis and overall survival and also some cellular markers which may affect CLL clinical status.
first_indexed 2024-04-11T17:51:14Z
format Article
id doaj.art-ab90cb79fa1e4998b59cafc8d9b68962
institution Directory Open Access Journal
issn 2228-6527
2228-5466
language English
last_indexed 2024-04-11T17:51:14Z
publishDate 2017-02-01
publisher Tehran University of Medical Sciences
record_format Article
series Basic & Clinical Cancer Research
spelling doaj.art-ab90cb79fa1e4998b59cafc8d9b689622022-12-22T04:11:06ZengTehran University of Medical SciencesBasic & Clinical Cancer Research2228-65272228-54662017-02-0184Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic ImpactMehrnoosh Pashaei0Mahdieh Shokrollahi1Parviz Kokhaei2Cancer Research Center and Department of Immunology, Semnan University of Medical Sciences,Semnan, Iran.Cancer Research Center and Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran. AND Immunology, Asthma and AllergyResearch Center, Tehran Universityof Medical Sciences, Tehran, Iran.Department of immunology, Semnan University of Medical Sciences, Semnan, Iran. AND Immune Gene therapy Lab Department of Oncology-Pathology,Immune and Gene therapy Lab,Cancer Center Karolinska , Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.Chronic lymphocyte leukemia (CLL) is the most common leukemia in elderly individuals that is accompanied by the presence of CD5/CD19/CD20/CD23 positive, FMC7 negative and reduced levels of surface membrane Immunoglobuline (IgM & IgD), CD79b on B lymphocytes in the blood, bone marrow and lymph nodes. Remarkably, based on the mutational IgVH status, B-CLL cases can be subdivided into two prognostic groups: the first one with presence mutation (≥ 2%) in VH gene and second one with absence mutation (≤ 2%) in VH gene that is the mutation of IgVH status, affected on progression and overall survival of CLL patients. Correspondingly, also the expression level of several markers is correlated with the mutation of IgVH status and prognosis of CLL disease. In this review we focused on relation between mutation IgVH status and CLL prognosis and overall survival and also some cellular markers which may affect CLL clinical status.https://bccr.tums.ac.ir/index.php/bccrj/article/view/218CLLmutation IgVH statusprognosis factoroverall survival
spellingShingle Mehrnoosh Pashaei
Mahdieh Shokrollahi
Parviz Kokhaei
Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact
Basic & Clinical Cancer Research
CLL
mutation IgVH status
prognosis factor
overall survival
title Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact
title_full Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact
title_fullStr Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact
title_full_unstemmed Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact
title_short Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact
title_sort somatic mutation in immunoglobulin gene variable region in patients with chronic lymphocytic leukemia and prognostic impact
topic CLL
mutation IgVH status
prognosis factor
overall survival
url https://bccr.tums.ac.ir/index.php/bccrj/article/view/218
work_keys_str_mv AT mehrnooshpashaei somaticmutationinimmunoglobulingenevariableregioninpatientswithchroniclymphocyticleukemiaandprognosticimpact
AT mahdiehshokrollahi somaticmutationinimmunoglobulingenevariableregioninpatientswithchroniclymphocyticleukemiaandprognosticimpact
AT parvizkokhaei somaticmutationinimmunoglobulingenevariableregioninpatientswithchroniclymphocyticleukemiaandprognosticimpact